115 related articles for article (PubMed ID: 6306745)
1. Improved therapeutic index of cis-diammine dichloro platinum by diethyldithiocarbamate in rodents.
Khandekar JD
Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):55-66. PubMed ID: 6306745
[TBL] [Abstract][Full Text] [Related]
2. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
3. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
Bodenner DL; Dedon PC; Keng PC; Borch RF
Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
[TBL] [Abstract][Full Text] [Related]
4. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
5. Modification of the bone marrow toxicity of cis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate.
Evans RG; Wheatley C; Engel C; Nielsen J; Ciborowski LJ
Cancer Res; 1984 Sep; 44(9):3686-90. PubMed ID: 6331656
[TBL] [Abstract][Full Text] [Related]
6. Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II).
Gonias SL; Oakley AC; Walther PJ; Pizzo SV
Cancer Res; 1984 Dec; 44(12 Pt 1):5764-70. PubMed ID: 6209003
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
8. Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity.
Gale GR; Atkins LM; Walker EM
Ann Clin Lab Sci; 1982; 12(5):345-55. PubMed ID: 6291445
[No Abstract] [Full Text] [Related]
9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
Howell SB; Taetle R
Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
[TBL] [Abstract][Full Text] [Related]
13. Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice.
Hacker MP; Ershler WB; Newman RA; Gamelli RL
Cancer Res; 1982 Nov; 42(11):4490-4. PubMed ID: 6290038
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum.
Allan SG; Smyth JF; Hay FG; Leonard RC; Wolf CR
Cancer Res; 1986 Jul; 46(7):3569-73. PubMed ID: 3085925
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
Ribaud P; Gouveia J; Bonnay M; Mathe G
Cancer Treat Rep; 1981; 65 Suppl 3():97-105. PubMed ID: 7049371
[TBL] [Abstract][Full Text] [Related]
17. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
18. Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.
Prestayko AW; Bradner WT; Huftalen JB; Rose WC; Schurig JE; Cleare MJ; Hydes PC; Crooke ST
Cancer Treat Rep; 1979; 63(9-10):1503-8. PubMed ID: 498150
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance induction and cross-resistance studies with Pt-complexes.
Hrubisko M; Balázová E; Ujházy V
Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
[TBL] [Abstract][Full Text] [Related]
20. Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbamate during and following exposure of plateau-phase cultures of mammalian cells to radiation and cis-diamminedichloroplatinum(II).
Evans RG; Engel C; Wheatley C; Nielsen J
Cancer Res; 1982 Aug; 42(8):3074-8. PubMed ID: 6284357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
